CHANGES IN WITHIN- AND BETWEEN-INDIVIDUAL BP VARIABILITY WITH BETA-BLOCKER, DIURETIC AND CALCIUM ANTAGONIST
Théodora Bejan‐Angoulvant, François Gueyffier(Centre National de la Recherche Scientifique), Stuart Pocock(London School of Hygiene & Tropical Medicine), Jan A. Staessen(Jagiellonian University), Hadrien Charvat(Juntendo University), James M Wright(University of British Columbia), Florent Boutitie(Université Claude Bernard Lyon 1), Marco I Perez(University of British Columbia), Vijaya M Musini(University of British Columbia)
Cited by 0
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
|New England Journal of Medicine|2004|1.5k
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k